We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Article |


C. Venkata S. Ram, MD
Arch Intern Med. 1982;142(5):914-916. doi:10.1001/archinte.1982.00340180072016.
Text Size: A A A
Published online


Ferreira SH:  A bradykinin-potentiating factor (BPF) present in venom of Bothrops jararca. Br J Pharmacol 1965;24:163-169.
Ferguson RK, Brunner HR, Turin GA, et al:  A specific orally active inhibitor of converting enzyme in man. Lancet 1977;1:775-778.
Link to Article[[XSLOpenURL/10.1016/S0140-6736(77)92958-0]]
Swartz SL, Williams GH, Hollenberg NK, et al:  Endocrine profile in the long-term phase of converting enzyme inhibition. Clin Pharmacol Ther 1980;28:499-508.
Link to Article[[XSLOpenURL/10.1038/clpt.1980.194]]
Johns DW, Baker KM, Ayers CR, et al:  Acute and chronic effect of captopril in hypertensive patients. Hypertension 1980;2:567-575.
Link to Article[[XSLOpenURL/10.1161/01.HYP.2.4.567]]
Case DB, Atlas SA, Laragh JH, et al:  Clinical experience with blockade of the renin-angiotensin-aldosterone system by an oral converting enzyme inhibitor, SQ14225, captopril, in hypertensive patients. Prog Cardiovasc Dis 1978;21:195-206.
Link to Article[[XSLOpenURL/10.1016/0033-0620(78)90025-7]]
Brunner HR, Gavras H, Waeber B, et al:  Oral angiotensin converting enzyme inhibitor in long-term treatment of hypertensive patients. Ann Intern Med 1979;90:19-23.
Link to Article[[XSLOpenURL/10.7326/0003-4819-90-1-19]]
Jenkins AC, McKinstry DN:  Review of clinical studies of hypertensive patients treated with captopril. Med J Aust 1979;2( (suppl 2) ):32-37.
Friedlander DH:  Comparison of captopril with propranolol in the treatment of essential hypertension. Med J Aust 1979;2( (suppl 2) ):30-32.
Ferguson RK, Vlasses DH, Koplin JR, et al:  Captopril in severe treatment-resistant hypertension. Am Heart J 1980;99:579-585.
Link to Article[[XSLOpenURL/10.1016/0002-8703(80)90730-9]]
Atkinson AB, Brown JJ, Lever AF, et al:  Combined treatment of severe intractable hypertension with captopril and diuretics. Lancet 1980;2:105-107.
Link to Article[[XSLOpenURL/10.1016/S0140-6736(80)90001-X]]
Banks RA, Markandund ND, Roulston JE, et al: Differing effects of sodium restriction, spironolactone, propranolol with captopril in black and white patients with hypertension, abstracted. Read before the International Society of Hypertension, Milan, Italy, June 1-3, 1981.
Johnston CI, McGrath BD, Millar JA, et al:  Long-term effects of captopril (SQ 14225) on blood pressure and hormone levels in essential hypertension. Lancet 1977;2:493-495.
Laragh JH, Case DB, Atlas SA, et al:  Captopril compared with other anti-renin system agents in hypertensive patients: Its triphasic effects on blood pressure and its use to identify and treat the renin factor. Hypertension 1980;2:586-593.
Link to Article[[XSLOpenURL/10.1161/01.HYP.2.4.586]]
Vaughan ED Jr, Carey RM, Ayers CR, et al:  Hemodialysis-resistant hypertension: Control with orally active inhibitor of angiotensin converting enzyme. J Clin Endocrinol Metab 1979;48:869-871.
Link to Article[[XSLOpenURL/10.1210/jcem-48-5-869]]
D'Angelo WA, Lopez-Overjo JA, Soral SD, et al:  Early versus late treatment of sclerodermal renal crisis and malignant hypertension with captopril, abstracted. Arthritis Rheum 1980;23:664.
Dzau VJ, Colucci WS, Williams GH, et al:  Sustained effectiveness of converting enzyme inhibition in patients with severe congestive heart failure. N Engl J Med 1980;302:1373-1379.
Link to Article[[XSLOpenURL/10.1056/NEJM198006193022501]]
Faxon DP, Halperin JL, Creager MA, et al:  Angiotensin inhibition in severe heart failure: Acute central and hemodynamic effects of captopril with observations on sustained oral therapy. Am Heart J 1981;101:548-556.
Link to Article[[XSLOpenURL/10.1016/0002-8703(81)90220-9]]
Linjen P, Fagard P, Staessen J, et al:  Dose response of captopril therapy on hypertension. Clin Pharmacol Ther 1980;28:310-315.
Link to Article[[XSLOpenURL/10.1038/clpt.1980.167]]
Captopril:  Benefit and risks in severe hypertension. Lancet 1980;2:129-130.
Gavras I, Graff LG, Rose BD, et al:  Fatal pancytopenia associated with the use of captopril. Ann Intern Med 1981;94:58-59.
Link to Article[[XSLOpenURL/10.7326/0003-4819-94-1-58]]
Case DB, Atlas SA, Mourandian JA, et al:  Proteinuria during long-term captopril therapy. JAMA 1980;244:346-349.
Link to Article[[XSLOpenURL/10.1001/jama.1980.03310040028020]]
Hoorntje SJ, Kallenberg CGM, Weening JJ, et al:  Immune-complex glomerulopathy in patients treated with captopril. Lancet 1980;1:1212-1214.
Link to Article[[XSLOpenURL/10.1016/S0140-6736(80)91677-3]]
McNeil JJ, Anderson A, Christophidis N, et al:  Taste loss associated with oral captopril treatment. Br Med J 1979;2:1555-1556.
Link to Article[[XSLOpenURL/10.1136/bmj.2.6204.1555-a]]


Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

First Page Preview

View Large
First page PDF preview





Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

0 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.